LncRNA DANCR accelerates the development of multidrug resistance of gastric cancer.
CONCLUSIONS: Upregulation of DANCR can accelerate the MDR development of GC, which may become a potential target for treating GC with MDR.
PMID: 31002130 [PubMed - in process]
Source: European Review for Medical and Pharmacological Sciences - Category: Drugs & Pharmacology Tags: Eur Rev Med Pharmacol Sci Source Type: research
More News: Cancer | Cancer & Oncology | Drugs & Pharmacology | Gastric (Stomach) Cancer | Gastroenterology | Multidrug Resistance | Study